Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Apr-24 4:30 PM View:  | Boundless Bio, Inc. (BOLD) | 02-Apr-24 | Conversion | 525,274 | -- | -- | 410% 128.21K to 653.48K | |
| 06-Dec-23 7:41 PM View: | Erasca, Inc. (ERAS) | 06-Dec-23 | Purchase | 278,150 | $1.72 | $478,418.00 | < 1% 32.08M to 32.36M | |
| 06-Dec-23 7:41 PM View: | Erasca, Inc. (ERAS) | 05-Dec-23 | Private Purchase | 721,850 | $1.69 | $1,217,760.00 | 2% 31.63M to 32.36M | |
| 10-Oct-23 8:00 AM View: | Erasca, Inc. (ERAS) | 05-Oct-23 | Private Purchase | 1,000,000 | $2.03 | $2,026,000.00 | 3% 30.36M to 31.36M | |
| 08-Jun-23 8:54 PM View: | Erasca, Inc. (ERAS) | 08-Jun-23 | Private Purchase | 100,000 | $2.75 | $275,000.00 | < 1% 30.2M to 30.3M | |
| 28-Mar-23 9:24 PM View: | Erasca, Inc. (ERAS) | 28-Mar-23 | Private Purchase | 100,000 | $2.84 | $284,000.00 | < 1% 30.1M to 30.2M | |
| 10-Jan-23 4:46 PM View: | Erasca, Inc. (ERAS) | 10-Jan-23 | Private Purchase | 60,000 | $3.86 | $231,420.00 | < 1% 32.1M to 32.16M | |
| 15-Dec-22 11:53 AM View: | Erasca, Inc. (ERAS) | 14-Dec-22 | Private Purchase | 40,000 | $4.99 | $199,600.00 | < 1% 32.06M to 32.1M | |
| 15-Feb-23 10:00 PM View: | Erasca, Inc. (ERAS) | 30-Nov-22 | Gift | 2,000,010 | -- | -- | (6%) 32.1M to 30.1M | |
| 20-Jul-21 8:58 PM View: | Erasca, Inc. (ERAS) | 20-Jul-21 | Conversion | 10,576,400 | -- | -- | 49% 21.48M to 32.06M | |
| 12-Feb-18 3:33 PM View: | Ignyta, Inc. (RXDX) | 08-Feb-18 | Disposition | 179,661 | $27.00 | $4,850,850.00 | (5%) 3.53M to 3.35M | |
| 12-Feb-18 3:33 PM View: | Ignyta, Inc. (RXDX) | 08-Feb-18 | Disposition | 3,350,000 | $27.00 | $90,450,000.00 | (100%) 3.35M to 0 | |
| 28-Dec-17 9:34 PM View: | Ignyta, Inc. (RXDX) | 26-Dec-17 | Payment of Exercise | 19,006 | $26.70 | $507,460.00 | (< 1%) 3.55M to 3.53M | |
| 22-Dec-17 9:47 PM View: | Ignyta, Inc. (RXDX) | 22-Dec-17 | Grant | 68,334 | -- | -- | 52% 130.33K to 198.67K | |
| 10-Mar-17 8:05 PM View: | Ignyta, Inc. (RXDX) | 13-Feb-17 | Option Exercise | 6,945 | $0.60 | $4,167.00 | < 1% 3.47M to 3.48M | |
| 13-Apr-16 7:12 PM View: | Ignyta, Inc. (RXDX) | 11-Apr-16 | Option Exercise | 26,388 | $0.60 | $15,832.80 | < 1% 3.45M to 3.47M | |
| 21-Mar-16 12:46 PM View: | Ignyta, Inc. (RXDX) | 17-Mar-16 | Market Purchase Duplicate | 24,852 | $5.51 | $136,880.00 | < 1% 3.42M to 3.45M | (14%) |
| 11-Jan-16 6:14 PM View: | Ignyta, Inc. (RXDX) | 07-Jan-16 | Grant | 72,000 | -- | -- | 288% 25.0K to 97.0K | |
| 21-Aug-15 4:49 PM View: | Ignyta, Inc. (RXDX) | 20-Aug-15 | Market Purchase Duplicate | 1,740 | $12.69 | $22,083.50 | < 1% 3.35M to 3.35M | (63%) |
| 21-Aug-15 4:49 PM View: | Ignyta, Inc. (RXDX) | 19-Aug-15 | Market Purchase Duplicate | 6,740 | $12.96 | $87,318.70 | < 1% 3.34M to 3.35M | (63%) |
| 24-Mar-15 5:14 PM View: | Ignyta, Inc. (RXDX) | 20-Mar-15 | Market Purchase | 20,000 | $9.01 | $180,200.00 | < 1% 3.32M to 3.34M | (47%) |
| 19-Aug-14 9:00 PM View: | Ignyta, Inc. (RXDX) | 15-Aug-14 | Market Purchase | 5,000 | $7.60 | $37,997.00 | < 1% 3.32M to 3.32M | (37%) |
| 14-Jan-10 7:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Jan-10 | Option Exercise | 30,000 | $0.39 | $11,700.00 | 4% 680.0K to 710.0K | |
| 24-Mar-08 6:20 PM View: | Halozyme Therapeutics, Inc. (HALO) | 20-Mar-08 | Market Sale | 250,000 | $6.06 | $1,515,000.00 | (27%) 930.0K to 680.0K | 100% |
| 21-Mar-08 4:30 PM View: | Halozyme Therapeutics, Inc. (HALO) | 19-Mar-08 | Option Exercise | 230,000 | $0.39 | $89,700.00 | 33% 700.0K to 930.0K | 1572% |
| 04-Dec-07 4:26 PM View: | Halozyme Therapeutics, Inc. (HALO) | 30-Nov-07 | Option Exercise | 20,000 | $0.39 | $7,800.00 | 3% 700.0K to 720.0K | |
| 04-Dec-07 4:26 PM View: | Halozyme Therapeutics, Inc. (HALO) | 30-Nov-07 | Market Option Sale (Planned) | 20,000 | $8.24 | $164,796.00 | (3%) 720.0K to 700.0K | 100% |
| 02-Nov-07 4:25 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Oct-07 | Option Exercise | 25,000 | $0.39 | $9,750.00 | 4% 700.0K to 725.0K | |
| 02-Nov-07 4:25 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Oct-07 | Market Option Sale (Planned) | 25,000 | $9.03 | $225,850.00 | (3%) 725.0K to 700.0K | 100% |
| 16-Oct-07 8:31 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Oct-07 | Option Exercise | 26,690 | $0.45 | $11,999.80 | 4% 673.31K to 700.0K | |
| 02-Oct-07 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 28-Sep-07 | Option Exercise | 25,000 | $0.39 | $9,750.00 | 4% 673.31K to 698.31K | |
| 02-Oct-07 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 28-Sep-07 | Market Option Sale (Planned) | 25,000 | $8.78 | $219,524.00 | (4%) 698.31K to 673.31K | 100% |
| 31-Aug-07 8:07 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Aug-07 | Option Exercise | 25,000 | $0.39 | $9,750.00 | 4% 673.31K to 698.31K | |
| 31-Aug-07 8:07 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Aug-07 | Market Option Sale (Planned) | 12,200 | $8.57 | $104,508.00 | (2%) 698.31K to 686.11K | 100% |
| 31-Aug-07 8:11 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Aug-07 | Market Sale (Planned) | 12,800 | $8.82 | $112,840.00 | (2%) 686.11K to 673.31K | 100% |
| 02-Aug-07 4:16 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Jul-07 | Option Exercise | 20,000 | $0.39 | $7,800.00 | 3% 673.31K to 693.31K | |
| 02-Aug-07 4:16 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Jul-07 | Market Option Sale (Planned) | 20,000 | $8.20 | $163,933.00 | (3%) 693.31K to 673.31K | 100% |
| 02-Jul-07 10:38 AM View: | Halozyme Therapeutics, Inc. (HALO) | 29-Jun-07 | Option Exercise | 25,000 | $0.39 | $9,750.00 | 4% 673.31K to 698.31K | |
| 02-Jul-07 10:38 AM View: | Halozyme Therapeutics, Inc. (HALO) | 29-Jun-07 | Market Option Sale (Planned) | 16,801 | $9.43 | $158,376.00 | (2%) 698.31K to 681.51K | 100% |
| 02-Jul-07 10:39 AM View: | Halozyme Therapeutics, Inc. (HALO) | 29-Jun-07 | Market Sale (Planned) | 8,199 | $9.59 | $78,594.40 | (1%) 681.51K to 673.31K | 100% |
| 26-Jun-07 5:57 PM View: | Halozyme Therapeutics, Inc. (HALO) | 25-Jun-07 | Option Exercise | 96,313 | $0.39 | $37,562.10 | 17% 577.0K to 673.31K | |
| 01-Jun-07 6:21 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-May-07 | Option Exercise | 12,500 | $0.39 | $4,875.00 | 2% 589.5K to 602.0K | |
| 01-Jun-07 6:21 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-May-07 | Market Option Sale (Planned) | 12,500 | $10.35 | $129,320.00 | (2%) 602.0K to 589.5K | 100% |
| 01-Jun-07 6:21 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-May-07 | Market Sale (Planned) | 6,600 | $10.35 | $68,281.20 | (1%) 589.5K to 582.9K | 100% |
| 01-Jun-07 6:24 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-May-07 | Market Sale (Planned) | 5,900 | $10.59 | $62,469.40 | (1%) 582.9K to 577.0K | 100% |
| 24-Mar-05 10:00 PM View: | Halozyme Therapeutics, Inc. (HALO) | 24-Mar-05 | Option Exercise | 100,000 | $0.39 | $39,000.00 | 20% 489.5K to 589.5K | |
| 18-Aug-04 7:46 PM View: | Halozyme Therapeutics, Inc. (HALO) | 18-Aug-04 | Market Purchase | 5,000 | $1.61 | $8,050.00 | 1% 484.5K to 489.5K | (100%) |